Lactobacillus rhamnosus L34 attenuates gut translocationinduced bacterial sepsis in murine models of leaky gut

Infection and Immunity

Volumn 86, Issue 1, 2018, Pages

  Panpetch, Wimonrat ^a   Chancharoenthana, Wiwat ^b   Bootdee, Kanthika ^a   Nilgate, Sumanee ^a   Finkelman, Malcolm ^c   Tumwasorn, Somying ^a   Leelahavanichkul, Asada ^a,d  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b CHULABHORN GRADUATE INSTITUTE   (Thailand)

^c Associates of Cape Cod Inc   (United States)

^d CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Antibiotics; Dextran sulfate solution; Gastrointestinal leakage; Lactobacillus rhamnosus L34; Murine model

Indexed keywords

ANTIBIOTIC AGENT; DEXTRAN SULFATE; FLUORESCEIN ISOTHIOCYANATE; INTERLEUKIN 6; INTERLEUKIN 8; PROBIOTIC AGENT;

ACINETOBACTER BAUMANNII; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ESCHERICHIA COLI; GASTROINTESTINAL DISEASE; GASTROINTESTINAL LEAKAGE; HT-29 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATORY CELL; INTESTINE EPITHELIUM CELL; KLEBSIELLA PNEUMONIAE; LACTOBACILLUS RHAMNOSUS; MALE; MORTALITY; MORTALITY RATE; MOUSE; MURINE MODEL; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SEPSIS; SIGNAL TRANSDUCTION; THERAPY EFFECT; ANIMAL; BACTEREMIA; COLON; DISEASE MODEL; EPITHELIUM CELL; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; BACTEREMIA; BACTERIAL TRANSLOCATION; COLON; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; INTERLEUKIN-6; LACTOBACILLUS RHAMNOSUS; MALE; MICE; MICE, INBRED ICR; PROBIOTICS; SEPSIS;

EID: 85039561573     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00700-17     Document Type: Article

References (57)

1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. 2016. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801-810. https://doi.org/10.1001/jama.2016.0287
2. Leelahavanichkul A, Panpetch W, Worasilchai N, Somparn P, Chancharoenthana W, Nilgate S, Finkelman M, Chindamporn A, Tumwasorn S. 2016. Evaluation of gastrointestinal leakage using serum (1-3)-beta-D-glucan in a Clostridium difficile murine model. FEMS Microbiol Lett 363:fnw204. https://doi.org/10.1093/femsle/fnw204
3. Leelahavanichkul A, Worasilchai N, Wannalerdsakun S, Jutivorakool K, Somparn P, Issara-Amphorn J, Tachaboon S, Srisawat N, Finkelman M, Chindamporn A. 2016. Gastrointestinal leakage detected by serum (1-3)-beta-D-glucan in mouse models and a pilot study in patients with sepsis. Shock 46:506-518. https://doi.org/10.1097/SHK.0000000000000645
4. Rowlands BJ, Soong CV, Gardiner KR. 1999. The gastrointestinal tract as a barrier in sepsis. Br Med Bull 55:196-211. https://doi.org/10.1258/0007142991902213
5. MacFie J, O'Boyle C, Mitchell CJ, Buckley PM, Johnstone D, Sudworth P. 1999 Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 45:223-228. https://doi.org/10.1136/gut.45.2.223
6. Francino MP. 2015. Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances. Front Microbiol 6:1543. https://doi .org/10.3389/fmicb.2015.01543
7. Knoop KA, McDonald KG, Kulkarni DH, Newberry RD. 2016. Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut 65:1100-1109. https://doi.org/10.1136/gutjnl-2014-309059
8. Guttman JA, Finlay BB. 2009. Tight junctions as targets of infectious agents. Biochim Biophys Acta 1788:832-841. https://doi.org/10.1016/j .bbamem.2008.10.028
9. Jepson MA, Schlecht HB, Collares-Buzato CB. 2000. Localization of dysfunctional tight junctions in Salmonella enterica serovar Typhimuriuminfected epithelial layers. Infect Immun 68:7202-7208. https://doi.org/10 .1128/IAI.68.12.7202-7208.2000
10. Hsu CR, Pan YJ, Liu JY, Chen CT, Lin TL, Wang JT. 2015. Klebsiella pneumoniae translocates across the intestinal epithelium via Rho GTPase-and phosphatidylinositol 3-kinase/Akt-dependent cell invasion. Infect Immun 83:769-779. https://doi.org/10.1128/IAI.02345-14
11. Tafazoli F, Magnusson KE, Zheng L. 2003. Disruption of epithelial barrier integrity by Salmonella enterica serovar Typhimurium requires geranylgeranylated proteins. Infect Immun 71:872-881. https://doi.org/10 .1128/IAI.71.2.872-881.2003
12. Kanoksil M, Jatapai A, Peacock SJ, Limmathurotsakul D. 2013. Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance study. PLoS One 8:e54714. https://doi.org/10.1371/journal.pone.0054714
13. McFarland LV. 2014. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open 4:e005047. https://doi.org/10.1136/bmjopen-2014-005047
14. Liu DQ, Gao QY, Liu HB, Li DH, Wu SW. 2013. Probiotics improve survival of septic rats by suppressing conditioned pathogens in ascites. World J Gastroenterol 19:4053-4059. https://doi.org/10.3748/wjg.v19.i25.4053
15. Khailova L, Frank DN, Dominguez JA, Wischmeyer PE. 2013. Probiotic administration reduces mortality and improves intestinal epithelial homeostasis in experimental sepsis. Anesthesiology 119:166-177. https://doi.org/10.1097/ALN.0b013e318291c2fc
16. Khailova L, Petrie B, Baird CH, Dominguez Rieg JA, Wischmeyer PE. 2014. Lactobacillus rhamnosus GG and Bifidobacterium longum attenuate lung injury and inflammatory response in experimental sepsis. PLoS One 9:e97861. https://doi.org/10.1371/journal.pone.0097861
17. Arribas B, Rodriguez-Cabezas ME, Camuesco D, Comalada M, Bailon E, Utrilla P, Nieto A, Concha A, Zarzuelo A, Galvez J. 2009. A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice. Br J Pharmacol 157:1024-1033. https://doi.org/10.1111/j.1476-5381.2009 .00270.x
18. Boyle RJ, Robins-Browne RM, Tang ML. 2006. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 83:1256-1264; quiz 1446-1447
19. Boonma P, Spinler JK, Venable SF, Versalovic J, Tumwasorn S. 2014. Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clostridium difficile-induced IL-8 production by colonic epithelial cells. BMC Microbiol 14:177. https://doi.org/10.1186/1471-2180-14-177
20. Eftang LL, Esbensen Y, Tannaes TM, Bukholm IR, Bukholm G. 2012. Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells. BMC Microbiol 12:9. https://doi.org/10.1186/1471-2180-12-9
21. Balzan S, de Almeidaq Uadros C, de Cleva R, Zilberstein B, Cecconello I. 2007. Bacterial translocation: overview of mechanisms and clinical impact. J Gastroenterol Hepatol 22:464-471. https://doi.org/10.1111/j.1440-1746.2007.04933.x
22. Mittrucker HW, Kaufmann SH. 2000. Immune response to infection with Salmonella typhimurium in mice. J Leukoc Biol 67:457-463
23. Awad WA, Hess C, Hess M. 2017. Enteric pathogens and their toxin-induced disruption of the intestinal barrier through alteration of tight junctions in chickens. Toxins (Basel) 9:E60. https://doi.org/10.3390/toxins9020060
24. Mohawk KL, Melton-Celsa AR, Zangari T, Carroll EE, O'Brien AD. 2010. Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora. Microb Pathog 48:131-142. https://doi.org/10.1016/j.micpath.2010.01.003
25. Baumler AJ, Sperandio V. 2016. Interactions between the microbiota and pathogenic bacteria in the gut. Nature 535:85-93. https://doi.org/10 .1038/nature18849
26. Stecher B, Macpherson AJ, Hapfelmeier S, Kremer M, Stallmach T, Hardt WD. 2005. Comparison of Salmonella enterica serovar Typhimurium colitis in germfree mice and mice pretreated with streptomycin. Infect Immun 73:3228-3241. https://doi.org/10.1128/IAI.73.6.3228-3241.2005
27. Vazquez-Torres A, Jones-Carson J, Baumler AJ, Falkow S, Valdivia R, Brown W, Le M, Berggren R, Parks WT, Fang FC. 1999. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401:804-808. https://doi.org/10.1038/44593
28. Langdon A, Crook N, Dantas G. 2016. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med 8:39. https://doi.org/10.1186/s13073-016-0294-z
29. Shimizu K, Ogura H, Asahara T, Nomoto K, Morotomi M, Tasaki O, Matsushima A, Kuwagata Y, Shimazu T, Sugimoto H. 2013. Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective. Dig Dis Sci 58:23-32. https://doi.org/10.1007/s10620-012-2334-x
30. Zhang GQ, Hu HJ, Liu CY, Shakya S, Li ZY. 2016. Probiotics for preventing late-onset sepsis in preterm neonates: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 95:e2581. https://doi.org/10.1097/MD.0000000000002581
31. Tok D, Ilkgul O, Bengmark S, Aydede H, Erhan Y, Taneli F, Ulman C, Vatansever S, Kose C, Ok G. 2007. Pretreatment with pro-and synbiotics reduces peritonitis-induced acute lung injury in rats. J Trauma 62: 880-885. https://doi.org/10.1097/01.ta.0000236019.00650.00
32. Netea MG, Joosten LA, van der Meer JW, Kullberg BJ, van de Veerdonk FL. 2015. Immune defence against Candida fungal infections. Nat Rev Immunol 15:630-642. https://doi.org/10.1038/nri3897
33. Deitch EA. 2012. Gut-origin sepsis: evolution of a concept. Surgeon 10:350-356. https://doi.org/10.1016/j.surge.2012.03.003
34. Jacobi CA, Schulz C, Malfertheiner P. 2011. Treating critically ill patients with probiotics: beneficial or dangerous? Gut Pathog 3:2. https://doi.org/10.1186/1757-4749-3-2
35. Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, Tilg H, Watson A, Wells JM. 2014. Intestinal permeability-a new target for disease prevention and therapy. BMC Gastroenterol 14:189. https://doi.org/10.1186/s12876-014-0189-7
36. Verna EC, Lucak S. 2010. Use of probiotics in gastrointestinal disorders: what to recommend? Therap Adv Gastroenterol 3:307-319. https://doi .org/10.1177/1756283X10373814
37. Li XQ, Zhu YH, Zhang HF, Yue Y, Cai ZX, Lu Q P, Zhang L, Weng XG, Zhang FJ, Zhou D, Yang JC, Wang JF. 2012. Risks associated with high-dose Lactobacillus rhamnosus in an Escherichia coli model of piglet diarrhoea: intestinal microbiota and immune imbalances. PLoS One 7:e40666. https://doi.org/10.1371/journal.pone.0040666
38. Wen K, Li G, Bui T, Liu F, Li Y, Kocher J, Lin L, Yang X, Yuan L. 2012. High dose and low dose Lactobacillus acidophilus exerted differential im-mune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs. Vaccine 30:1198-1207. https://doi.org/10.1016/j.vaccine.2011.11.107
39. Zhang L, Li N, Caicedo R, Neu J. 2005. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J Nutr 135:1752-1756
40. Panpetch W, Spinler JK, Versalovic J, Tumwasorn S. 2016. Characterization of Lactobacillus salivarius strains B37 and B60 capable of inhibiting IL-8 production in Helicobacter pylori-stimulated gastric epithelial cells. BMC Microbiol 16:242. https://doi.org/10.1186/s12866-016-0861-x
41. Wells JM. 2011. Immunomodulatory mechanisms of lactobacilli. Microb Cell Fact 10(Suppl 1):S17. https://doi.org/10.1186/1475-2859-10-S1-S17
42. Hosono A, Lee J, Ametani A, Natsume M, Hirayama M, Adachi T, Kaminogawa S. 1997. Characterization of a water-soluble polysaccharide fraction with immunopotentiating activity from Bifidobacterium adolescentis M101-4. Biosci Biotechnol Biochem 61:312-316. https://doi.org/10.1271/bbb.61.312
43. Matsumoto S, Hara T, Hori T, Mitsuyama K, Nagaoka M, Tomiyasu N, Suzuki A, Sata M. 2005. Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol 140:417-426. https://doi.org/10.1111/j .1365-2249.2005.02790.x
44. Wu MH, Pan TM, Wu YJ, Chang SJ, Chang MS, Hu CY. 2010. Exopolysaccharide activities from probiotic bifidobacterium: immunomodulatory effects (on J774A.1 macrophages) and antimicrobial properties. Int J Food Microbiol 144:104-110. https://doi.org/10.1016/j.ijfoodmicro.2010 .09.003
45. Surayot U, Wang J, Seesuriyachan P, Kuntiya A, Tabarsa M, Lee Y, Kim JK, Park W, You S. 2014. Exopolysaccharides from lactic acid bacteria: structural analysis, molecular weight effect on immunomodulation. Int J Biol Macromol 68:233-240. https://doi.org/10.1016/j.ijbiomac.2014.05.005
46. Gao K, Wang C, Liu L, Dou X, Liu J, Yuan L, Zhang W, Wang H. 14 May 2015 Immunomodulation and signaling mechanism of Lactobacillus rhamnosus GG and its components on porcine intestinal epithelial cells stimulated by lipopolysaccharide. J Microbiol Immunol Infect https://doi .org/10.1016/j.jmii.2015.05.002
47. Seeley EJ, Matthay MA, Wolters PJ. 2012. Inflection points in sepsis biology: from local defense to systemic organ injury. Am J Physiol Lung Cell Mol Physiol 303:L355-L363. https://doi.org/10.1152/ajplung.00069 .2012
48. Jung E, Perrone EE, Liang Z, Breed ER, Dominguez JA, Clark AT, Fox AC, Dunne WM, Burd EM, Farris AB, Hotchkiss RS, Coopersmith CM. 2012. Cecal ligation and puncture followed by methicillin-resistant Staphylococcus aureus pneumonia increases mortality in mice and blunts production of local and systemic cytokines. Shock 37:85-94. https://doi.org/10.1097/SHK.0b013e3182360faf
49. Arrieta MC, Bistritz L, Meddings JB. 2006. Alterations in intestinal permeability. Gut 55:1512-1520. https://doi.org/10.1136/gut.2005.085373
50. Hurley JC, Guidet B, Offenstadt G, Maury E. 2012. Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders. Crit Care 16:R148. https://doi.org/10.1186/cc11462
51. Lu M, Munford RS. 2011. The transport and inactivation kinetics of bacterial lipopolysaccharide influence its immunological potency in vivo. J Immunol 187:3314-3320. https://doi.org/10.4049/jimmunol.1004087
52. Munford RS. 2016. Endotoxemia-menace, marker, or mistake? J Leukoc Biol 100:687-698. https://doi.org/10.1189/jlb.3RU0316-151R
53. Wong J, Zhang Y, Patidar A, Vilar E, Finkelman M, Farrington K. 2016. Is endotoxemia in stable hemodialysis patients an artefact? Limitations of the limulus amebocyte lysate assay and role of (1-3)-beta-D glucan. PLoS One 11:e0164978. https://doi.org/10.1371/journal.pone.0164978
54. Park SH, Kim HJ, Cho WH, Kim JH, Oh MH, Kim SH, Lee BK, Ricke SC, Kim HY. 2009. Identification of Salmonella enterica subspecies I, Salmonella enterica serovars Typhimurium, Enteritidis and Typhi using multiplex PCR. FEMS Microbiol Lett 301:137-146. https://doi.org/10.1111/j.1574-6968.2009.01809.x
55. Furrie E, Macfarlane S, Thomson G, Macfarlane GT, Microbiology & Gut Biology Group, Tayside Tissue & Tumour Bank. 2005. Toll-like receptors-2,-3 and-4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 115:565-574. https://doi.org/10.1111/j.1365-2567.2005.02200.x
56. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45. https://doi.org/10.1093/nar/29.9.e45
57. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC